MedPath

A clincial trial to compare the analgesic effect of a combination of Paracetamol and ibuprofen with paracetamol alone or ibuprofen alone in post tonsillectomy patinets.

Phase 3
Completed
Conditions
Health Condition 1: null- In Post opertaive tonsillectomy
Registration Number
CTRI/2009/091/000208
Lead Sponsor
AFT Pharmaceuticals New Zealand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

Present to study centre for routine tonsillectomy, under the care of a participating surgeon.

Be between 6-14 years of age on the day of consent.

Provide written informed consent before initiation of any study-related procedures from a parent or legal guardian and, where appropriate, written assent themselves.

We acknowledge that some children are able to provide consent, but will not recruit any subject unless both the patient and his or her parent or legal guardian are willing for this to occur and the parent or legal guardian must still provide his/her own consent.

Exclusion Criteria

Patients will be excluded from the study if any of the following exclusion criteria apply prior to randomization:
Study contra-indications
?Patient declines assent (or consent) or parent declines consent.
?Too young (<6 years) or too old (>14 years).
?Too small (weight below 15kg at base line visit).
?Having taken any NSAID or paracetamol within 12 hours prior to the operation.
?Known to be pregnant or possibly pregnant.
?Suffering from a neurological disorder relating to pain perception.
?In the opinion of the study staff, unable to understand the visual analogue pain score.
?Currently or in last 30 days, having participated in a clinical trial involving another study drug.
?Suffering from any other diseases or condition which, in the opinion of the investigator, means that it would not be in the patient?s best interests to participate in this study.
NSAID and/or paracetamol contra-indications
?Hypersensitivity to aspirin or other NSAID.
?Hypersensitivity to paracetamol.
?Severe known haemopoetic, renal or hepatic disease, immunosuppressant.
?History of gastric ulceration, indigestion, stomach pain or bleeding.
?Currently suffering from dehydration through diarrhoea and/or vomiting.
?History of severe asthma defined as previous steroid treatment or hospital admission.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath